- $1.50bn
- $1.29bn
- €1.29bn
- 83
- 64
- 55
- 75
Annual income statement for SGHC, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 476 | 908 | 1,321 | 1,292 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 486 | 748 | 1,106 | 1,334 |
| Operating Profit | -10 | 160 | 215 | -41.6 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -17.6 | 150 | 226 | 217 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -17.9 | 149 | 236 | 182 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -17.9 | 149 | 236 | 181 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -17.9 | 149 | 236 | 181 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.097 | 0.233 | 0.392 | 0.588 |
| Dividends per Share |